Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PBRM1 |
Variant | Q1298* |
Impact List | nonsense |
Protein Effect | loss of function |
Gene Variant Descriptions | PBRM1 Q1298* results in a premature truncation of the Pbrm1 protein at amino acid 1298 of 1689 (UniProt.org). Q1298* confers a loss of function to the Pbrm1 protein as demonstrated by loss of PBAF complex formation and the inability to inhibit cell proliferation in culture (PMID: 28082722). |
Associated Drug Resistance | |
Category Variants Paths |
PBRM1 mutant PBRM1 inact mut PBRM1 Q1298* |
Transcript | NM_181042.5 |
gDNA | chr3:g.52563477G>A |
cDNA | c.3892C>T |
Protein | p.Q1298* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001405556.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394869.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400474.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400501.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405581.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405593.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006765 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394868.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405626.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400500.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405594.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_181042.4 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006758 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405627.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405583.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405610.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394875.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405584.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400479.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405630.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006757 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006749 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405587.1 | chr3:g.52563333G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405640.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405641.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394872.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405609.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394878.1 | chr3:g.52563441G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405643.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405555.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006758.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006748.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405570.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001350075.2 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400470.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405577.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001350075.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405628.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405623.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_181042.5 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006749.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405631.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400496.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001400475.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394867.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006750.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006750 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
XM_017006748 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405557.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001394871.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
NM_001405603.1 | chr3:g.52563477G>A | c.3892C>T | p.Q1298* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|